BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34853344)

  • 1. Shape matters: morphological metrics of glioblastoma imaging abnormalities as biomarkers of prognosis.
    Curtin L; Whitmire P; White H; Bond KM; Mrugala MM; Hu LS; Swanson KR
    Sci Rep; 2021 Dec; 11(1):23202. PubMed ID: 34853344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study.
    Czarnek N; Clark K; Peters KB; Mazurowski MA
    J Neurooncol; 2017 Mar; 132(1):55-62. PubMed ID: 28074320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between necrotic patterns in glioblastoma and patient survival: fractal dimension and lacunarity analyses using magnetic resonance imaging.
    Liu S; Wang Y; Xu K; Wang Z; Fan X; Zhang C; Li S; Qiu X; Jiang T
    Sci Rep; 2017 Aug; 7(1):8302. PubMed ID: 28814802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractal-Based Morphometrics of Glioblastoma.
    Curtin L
    Adv Neurobiol; 2024; 36():545-555. PubMed ID: 38468052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma.
    Ingrisch M; Schneider MJ; Nörenberg D; Negrao de Figueiredo G; Maier-Hein K; Suchorska B; Schüller U; Albert N; Brückmann H; Reiser M; Tonn JC; Ertl-Wagner B
    Invest Radiol; 2017 Jun; 52(6):360-366. PubMed ID: 28079702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging based fractal analysis for differentiating primary CNS lymphoma and glioblastoma.
    Liu S; Fan X; Zhang C; Wang Z; Li S; Wang Y; Qiu X; Jiang T
    Eur Radiol; 2019 Mar; 29(3):1348-1354. PubMed ID: 30167811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
    Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
    Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.
    Pérez-Beteta J; Martínez-González A; Molina D; Amo-Salas M; Luque B; Arregui E; Calvo M; Borrás JM; López C; Claramonte M; Barcia JA; Iglesias L; Avecillas J; Albillo D; Navarro M; Villanueva JM; Paniagua JC; Martino J; Velásquez C; Asenjo B; Benavides M; Herruzo I; Delgado MD; Del Valle A; Falkov A; Schucht P; Arana E; Pérez-Romasanta L; Pérez-García VM
    Eur Radiol; 2017 Mar; 27(3):1096-1104. PubMed ID: 27329522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparameter MRI Predictors of Long-Term Survival in Glioblastoma Multiforme.
    Stringfield O; Arrington JA; Johnston SK; Rognin NG; Peeri NC; Balagurunathan Y; Jackson PR; Clark-Swanson KR; Swanson KR; Egan KM; Gatenby RA; Raghunand N
    Tomography; 2019 Mar; 5(1):135-144. PubMed ID: 30854451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.
    Grossman R; Shimony N; Shir D; Gonen T; Sitt R; Kimchi TJ; Harosh CB; Ram Z
    Ann Surg Oncol; 2017 Mar; 24(3):794-800. PubMed ID: 27766560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma.
    Grossmann P; Gutman DA; Dunn WD; Holder CA; Aerts HJ
    BMC Cancer; 2016 Aug; 16():611. PubMed ID: 27502180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative volumetric assessment of baseline enhancing tumor volume as an imaging biomarker predicts overall survival in patients with glioblastoma.
    Auer TA; Della Seta M; Collettini F; Chapiro J; Zschaeck S; Ghadjar P; Badakhshi H; Florange J; Hamm B; Budach V; Kaul D
    Acta Radiol; 2021 Sep; 62(9):1200-1207. PubMed ID: 32938221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Findings of DTI-p maps in comparison with T
    Beigi M; Safari M; Ameri A; Moghadam MS; Arbabi A; Tabatabaeefar M; SalighehRad H
    Cancer Imaging; 2018 Sep; 18(1):33. PubMed ID: 30227891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating angioarchitectural characteristics of glial and metastatic brain tumors with conventional magnetic resonance imaging.
    Abecassis IJ; Cordy B; Durfy S; Andre JB; Levitt MR; Ellenbogen RG; Silbergeld DL; Ko AL
    J Clin Neurosci; 2020 Jun; 76():46-52. PubMed ID: 32312627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients.
    Cordova JS; Shu HK; Liang Z; Gurbani SS; Cooper LA; Holder CA; Olson JJ; Kairdolf B; Schreibmann E; Neill SG; Hadjipanayis CG; Shim H
    Neuro Oncol; 2016 Aug; 18(8):1180-9. PubMed ID: 26984746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative study of shape descriptors from glioblastoma multiforme phenotypes for predicting survival outcome.
    Chaddad A; Desrosiers C; Hassan L; Tanougast C
    Br J Radiol; 2016 Dec; 89(1068):20160575. PubMed ID: 27781499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging.
    Kim R; Choi SH; Yun TJ; Lee ST; Park CK; Kim TM; Kim JH; Park SW; Sohn CH; Park SH; Kim IH
    Eur Radiol; 2017 Mar; 27(3):1176-1185. PubMed ID: 27357131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of tumor-derived MRI-texture features for discrimination of molecular subtypes and prediction of 12-month survival status in glioblastoma.
    Yang D; Rao G; Martinez J; Veeraraghavan A; Rao A
    Med Phys; 2015 Nov; 42(11):6725-35. PubMed ID: 26520762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas.
    Szeto MD; Chakraborty G; Hadley J; Rockne R; Muzi M; Alvord EC; Krohn KA; Spence AM; Swanson KR
    Cancer Res; 2009 May; 69(10):4502-9. PubMed ID: 19366800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of survival with multi-scale radiomic analysis in glioblastoma patients.
    Chaddad A; Sabri S; Niazi T; Abdulkarim B
    Med Biol Eng Comput; 2018 Dec; 56(12):2287-2300. PubMed ID: 29915951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.